Our Approach

Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. We have three investigational oncology programs in development for areas of high unmet medical need: QN-302, Pan-RAS, and QN-247.

More About Us

Our Therapeutics Pipeline

Our therapeutics pipeline includes cancer drug programs such as QN-302, Pan-RAS and QN-247.

Select a Drug Program to Learn More